Revisiting the debate: the use of new agents in previously untreated patients with small cell lung cancer; quality versus duration of survival.
作者信息
Markman M
出版信息
J Cancer Res Clin Oncol. 1994;120(12):693-4. doi: 10.1007/BF01194264.
Abstract
摘要
相似文献
1
Revisiting the debate: the use of new agents in previously untreated patients with small cell lung cancer; quality versus duration of survival.重新审视这场辩论：在既往未接受治疗的小细胞肺癌患者中使用新型药物；生存质量与生存时长
J Cancer Res Clin Oncol. 1994;120(12):693-4. doi: 10.1007/BF01194264.
2
Chemotherapy versus best supportive care for extensive small cell lung cancer.广泛期小细胞肺癌的化疗与最佳支持治疗对比
Cochrane Database Syst Rev. 2013 Nov 27;2013(11):CD001990. doi: 10.1002/14651858.CD001990.pub3.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
4
Long-term survival in small cell lung cancer patients is correlated with high interleukin-2 secretion at diagnosis.小细胞肺癌患者的长期生存与诊断时白细胞介素-2的高分泌相关。
J Cancer Res Clin Oncol. 2000 Dec;126(12):730-3. doi: 10.1007/pl00008479.
5
Parenteral anticoagulation may prolong the survival of patients with limited small cell lung cancer: a Cochrane systematic review.肠外抗凝治疗可能会延长局限期小细胞肺癌患者的生存期：一项Cochrane系统评价
J Exp Clin Cancer Res. 2008 May 15;27(1):4. doi: 10.1186/1756-9966-27-4.
6
Role of granulocyte and granulocyte-macrophage colony-stimulating factors in the treatment of small-cell lung cancer: a systematic review of the literature with methodological assessment and meta-analysis.粒细胞和粒细胞巨噬细胞集落刺激因子在小细胞肺癌治疗中的作用：一项具有方法学评估和荟萃分析的文献系统综述
Lung Cancer. 2002 Aug;37(2):115-23. doi: 10.1016/s0169-5002(02)00082-x.
7
Duration of chemotherapy in small cell lung cancer.小细胞肺癌的化疗疗程
Thorax. 1990 Jan;45(1):1-2. doi: 10.1136/thx.45.1.1.
8
Chemotherapy plus surgery versus surgery alone in non-small-cell lung cancer.非小细胞肺癌中化疗联合手术与单纯手术的对比
N Engl J Med. 1994 Jun 16;330(24):1756; author reply 1757. doi: 10.1056/NEJM199406163302413.
9
The debate about maintenance is not over in small-cell lung cancer.关于小细胞肺癌维持治疗的争论尚未结束。
J Clin Oncol. 2007 Dec 20;25(36):5840; author reply 5840-1. doi: 10.1200/JCO.2007.14.6183.
10
Early versus late chest radiotherapy for limited stage small cell lung cancer.局限期小细胞肺癌的早期与晚期胸部放疗
Cochrane Database Syst Rev. 2005 Jan 25;2004(1):CD004700. doi: 10.1002/14651858.CD004700.pub2.
本文引用的文献
1
Phase II trial of edatrexate in small cell lung cancer.依达曲沙治疗小细胞肺癌的II期试验。
Cancer. 1994 Feb 15;73(4):1189-93. doi: 10.1002/1097-0142(19940215)73:4<1189::aid-cncr2820730411>3.0.co;2-g.
2
Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.
J Clin Oncol. 1986 Apr;4(4):524-7. doi: 10.1200/JCO.1986.4.4.524.
3
4
Identification of new drugs in small cell lung cancer: phase II agents first?
Cancer Treat Rep. 1987 Dec;71(12):1131-3.
5
Phase II study of 1,2,4-triglycidylurazol (TGU) in previously untreated and treated patients with small cell lung cancer.1,2,4-三缩水甘油基脲唑（TGU）用于既往未接受治疗及已接受治疗的小细胞肺癌患者的II期研究。
Eur J Cancer Clin Oncol. 1987 Jul;23(7):1031-3. doi: 10.1016/0277-5379(87)90354-3.
6
Phase II study of amonafide: results of treatment and lessons learned from the study of an investigational agent in previously untreated patients with extensive small-cell lung cancer.氨萘非特的II期研究：在既往未经治疗的广泛期小细胞肺癌患者中使用一种研究性药物的治疗结果及经验教训
J Clin Oncol. 1990 Mar;8(3):390-5. doi: 10.1200/JCO.1990.8.3.390.
7
Epirubicin in extensive small-cell lung cancer: a phase II study in previously untreated patients: a National Cancer Institute of Canada Clinical Trials Group Study.表柔比星治疗广泛期小细胞肺癌：一项针对既往未接受治疗患者的II期研究：加拿大国家癌症研究所临床试验组研究
J Clin Oncol. 1990 Mar;8(3):385-9. doi: 10.1200/JCO.1990.8.3.385.
8
Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study.在选定的未经治疗的广泛期小细胞肺癌患者中评估新型抗癌药物的理由：一项东部肿瘤协作组的随机研究
J Natl Cancer Inst. 1992 Jul 15;84(14):1077-84. doi: 10.1093/jnci/84.14.1077.
9
Single-agent chemotherapy trials in small-cell lung cancer, 1970 to 1990: the case for studies in previously treated patients.
J Clin Oncol. 1992 Mar;10(3):484-98. doi: 10.1200/JCO.1992.10.3.484.
Zotero 插件